ALTHOUGH hypertension is only rarely caused by pheochromocytoma, when it is, it usually is completely reversible by excision of the tumor. Since 1927, when Mayo1 demonstrated that removal of an adrenal tumor resulted in cessation of hypertensive episodes, physicians have been looking for ways to detect the presence of this tumor when assessing patients who have hypertension. Even though Oliver and Schafer2 in 1895 demonstrated that adrenal medullary extract produced hypertension in animals, and Stolz3 synthesized epinephrine in 1904, it was not until 1957 that the first catecholamine metabolite, vanilmandelic acid (VMA), was described by Armstrong and associates. 4 During the ensuing decade much progress has been made in outlining the metabolic pathways of catecholamines (CA) . Whereas by Bollman and co-workers5 of the CA data on 48 patients with pheochromocytoma studied at the Mayo Clinic. Very little information was available then on metabolites of CA. The clinical data on the tumor patients seen through 1960 were reviewed by Gifford and co-workers.6) There were 28 patients with histologically proved pheochromocytoma and 148 other patients in whom this diagnosis was suspected but not confirmed either by surgical exploration (in 18) or by repeated study. In two cases, operation was performed specifically to search for tumor, while in the remaining cases the examination of the adrenals was incidental to abdominal surgery for other lesions.
The standard cold pressor-histamine test and the phentolamine (Regitine) test in combination with the determination of plasma CA were used as previously described. 7 The tyramine provocative test8 also was used toward the end of the study period. A positive result in the histamine test was defined as a pressor response of 20/10 mm Hg greater than the response to the cold pressor test; a positive result in the phentolamine test was a pressure decrease of 35/25 mm Hg compared to base-line values; a positive result in the tyramine test was a systolic pressor response of 20 mm Hg above base-line values.
Fluorometric procedures were used to determine the concentrations of plasma and urinary CA.9-11 Paper chromatographic methods were used to measure urinary concentrations of VMA,4 and homovanillic acid (HVA). any, change in plasma CA in eight tests, thus confirming that the pressor response to histamine is due to release of CA. Moreover, the level of plasma CA (or urinary metabolites) was not related to the development of a pressor response to histamine. Indeed, in one patient with metastatic pheochromocytoma studied many times over a period of 15 years,'6 dozens of histamine tests have been negative with greatly varying levels of tumor activity. respectively, after a second-stage thoracolumbar sympathectomy. No pheochromocytoma was found at autopsy a few weeks later. The possibility that the increased CA excretion was a reflection of release of CA from degenerating sympathetic tissue was explored in dogs. It was found that, within 10 days, the urinary CA increased as much after a sham procedure as after either the first or second stage of a total sympathectomy, thus confirming the clinical impression that this patient's high CA values were a response to nonspecific stress.
Histamine tests were positive in eight (11%) of 71 nontumor patients, and phentolamine tests were positive in five (11%) of 44; both tests were done in 14 of these cases. In none of these cases was plasma CA concentration increased although, on occasion, an increase in urinary output of either CA, MN, or VMA (once) was associated with a positive pharmacological test; in all instances, repeat pharmacological and biochemical studies gave normal results. Plasma CA concentrations were abnormal in two of 101 nontumor cases. In one patient a value of 6.1 pig/liter was obtained once, but five additional basal values were normal; slightly increased urinary values for CA were found in two of four urine specimens but VMA was normal and two phentolamine tests were negative (exploration was not done but follow-up has not revealed clinical evidence of pheochromocytoma). The other patient had abnormal plasma CA concentrations (7.5 to 10.0 .g/liter) five times, slightly abnormal urinary CA values twice, slightly abnormal MN value once (of two determinations), and normal VMA values twice; a histamine test was negative. A mass was noted in the para-aortic area on nephrotomography, but the patient refused to undergo operation and, 1 year later, was unchanged An additional interesting use of the plasma CA value is a "search" through the systemic veins for the location of the highest concentration of CA to localize a primary tumor29 or subsequent metastatic lesions. 21 Pharmacological tests for pheochromocytoma have been utilized at this institution since the description of the histamine test by Roth and Kvale30 in 1945. Our results with the phentolamine test were first described by Gifford and co-workers31 in 1952. Our experience with both of these tests up to 1961 was reviewed by Gifford and co-workers6 and illustrated the value of both tests in 72 patients with pheochromocytoma. Repeated pharmacological tests in five of these 72 patients gave negative results, and in four of these five the chemical tests gave positive results. In the present study, the established value of the histamine test is reconfirmed: 75% of tumor patients had positive results and only 11% of nontumor patients had false-positive results. The addition of plasma CA determinations further increased the diagnostic accuracy of this test.
Because of the frequent minor side effects (headaches, flushing) noted with histamine, other provocative agents have been proposed. Engelman and Sjoerdsma8 reasoned that, since tyramine is able to release CA from tissue depots and since these depots are greater in patients with pheochromocytoma, it would be a useful provocative agent. They were able to demonstrate a greater pressor response in six patients with pheochromocytoma than in normal subjects. We were able to confirm this in five of seven tumor patients, but the nature of the response made the test less suitable than the histamine test.17 More recently, glucagon32 and the ,8-blocking agents, propanolol and pronethanol,33 have been proposed as provocative agents; these interesting concepts will need confirmation.
The use of phentolamine in a pharmacological test for pheochromocytoma was based on Circulation, Volume XXXIV. September 1966 its ability to block briefly the effects of circulating CA. Thus, its greatest usefulness seems to be in testing patients with basal blood pressure so high that histamine was contraindicated and also in abbreviating a marked pressor response to histamine to provide an additional pharmacological test. In the latter situation it often was difficult to interpret the response of the blood pressure because there was no appropriate basal value for comparison, particularly when basal readings (before histamine) were normal. In the former situation, the degree of the response seemed to depend also on the basal pressure values, the greatest decreases being seen with the highest basal pressures. Patients with essential hypertension not infrequently had rather striking decreases in pressure; these decreases could be of quite long duration on rare occasions, and they occurred in the absence of any other predisposing diseases or drugs. 23 Myocardial infarction has been reported to occur as a consequence of such hypotension. 4 
Summary
The pharmacological and biochemical tests available for the diagnosis of pheochromocytoma were evaluated among 28 patients with proved tumors and 148 other patients in whom the diagnosis was suspected. Of the biochemical tests on urine, determinations of total metanephrines (MN) and of vanilmandelic acid (VMA) were much less subject to false-positive results than was determination of catecholamines (CA). Since urinary MN values changed the most in tumor patients, MN determination is preferred as the current screening test. Of the pharmacological tests, the histamine test continues to be the most valuable, especially when combined with determination of plasma CA concentration. The phentolamine (Regitine) test has not proved to be of any distinct value as a primary diagnostic aid. Any of the chemical or pharmacological tests occasionally may give a false-positive result. The urinary output of excessive amounts of homovanillic acid (HVA) was an indication of the presence of pheochromocytoma with some features histologically similar to other neural crest tumors but was not an indication of malignancy. Reliable diagnosis of pheochromocytoma still must be based on multiple studies in an appropriate clinical setting.
